Published
September 25, 2024
Updated
July 30, 2026
The PediaSure lawsuit challenges advertising claims that certain PediaSure products are clinically proven to promote children's growth.
Current Status
This is active litigation, not a settlement. On June 4, 2026, the court denied Abbott's motion for summary judgment, allowing the claims to continue. No settlement fund, claim form, deadline, or payment process exists.StatusActive litigation; no settlement
Latest MilestoneSummary judgment denied June 4, 2026
Claim FormNone
Potential PaymentNone currently available
What Is the Lawsuit About?
The plaintiff alleges Abbott marketed certain PediaSure products as clinically proven to help children grow without adequate substantiation. These remain allegations, and Abbott disputes them.Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Who Could Be Affected?
The proposed claims concern purchasers of covered PediaSure products. No settlement class or consumer claims process has been authorized.What Happens Next?
The case may proceed through further motions, trial, or a negotiated resolution. Consumers should rely on court records because no administrator has been appointed.Official Information
Review the latest information on the CourtListener docket search website.
Case Title
Noriega v. Abbott Laboratories
Case Number
7:23-cv-04014
Court
U.S. District Court for the Southern District of New York
Current Milestone
Case proceeding after June 4, 2026 ruling
Official Website
CourtListener docket search
For more class actions, recalls, and refunds, keep scrolling below.
